**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 555-30-6 |3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Ala| 99 | 209-089-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause allergic contact dermatitis.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause central nervous system effects such as
psychosis, hallucinations, depression, visual changes and mental
changes.
Inhalation:
Inhalation of dust may cause respiratory tract irritation.
Chronic:
May cause reproductive and fetal effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry,
closed container for disposal.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Avoid contact with eyes, skin, and clothing. Avoid ingestion and
inhalation.
Storage:
Keep container closed when not in use. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 555-30-6:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: white
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 300 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula: C10H13NO4.1.5H2O
Molecular Weight: 238.24
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, moisture.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 555-30-6: AY5950000
LD50/LC50:
CAS# 555-30-6: Oral, mouse: LD50 = 5300 mg/kg; Oral, rabbit: LD50 =
713 mg/kg; Oral, rat: LD50 = 5 gm/kg.
Carcinogenicity:
3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine,Sesquihydrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 555-30-6: 1
Canada
CAS# 555-30-6 is listed on Canada's DSL List.
CAS# 555-30-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 555-30-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/23/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-(3,4-Dihydroxyphenyl)-2-Methyl-l-Alanine Sesquihydrate, 99%
| 555-30-6 |
|
DL-2-Methylglutamic Acid Hemihydrate, 99%
| 71-90-9 |
|
Berberine hydrochloride hydrate, 97%
| 633-65-8 |
|
Triethanolamine salicylate, 99%
| 0-00-1 |
|
3'-(Trifluoromethoxy)acetophenone, 97%
| 170141-63-6 |
|
2-(Aminomethyl)pyridine, 99%
| 3731-51-9 |
|
Platinum(ii) bromide, 98%
| 13455-12-4 |
|
2-Hydroxy-6-aminopurine, 98%
| |
|
Trans-(+)-chrysanthemic acid, 99+%(gc)
| 4638-92-0 |
|
3,3'-Iminodipropionitrile, 99+% (GC)
| 111-94-4 |
|
Beta-d-thioglucose tetraacetate, 97%
| 28878-90-2 |
|
3-Hydroxy-4-Methoxybenzaldehyde, 98%
| 621-59-0 |
|
2-Naphthol-3,6-Disulfonic Acid Disodium Salt (Tech), 85% (UV-VIS)
| 135-51-3 |
|
4-Carboxybenzenesulfonyl azide, 99%(titr.)
| 17202-49-2 |
|
1-Methylcyclohexanol, 96%
| 590-67-0 |
|
N,N-Diethyl-4-Nitrosoaniline, 98%
| 120-22-9 |
|
2-Amino-2',5- Dichlorobenzophenone, 99%
| 2958-36-3 |
|
4-Hexyloxyphenol, 99%
| 18979-55-0 |
|
O,O-Bis(Diethoxyphosphoryl)Calix[4]Arene 97% (TLC)
| 0-01-1 |
|
3,4-Dihydro-2,2-Dimethyl-4-Oxo-2H-Pyran-6-Carboxylic Acid, 98%
| 80866-93-9 |
|
Lead Tetrafluoride, 99%
| 7783-59-7 |
|
4-Carbamoyl-2,2,5,5-tetramethyl-3-imidazol ine-3-oxide-1-oxyl,free
| 69826-43-3 |
|
N,N-Dimethylformamide dineopentyl acetal, 99%
| 4909-78-8 |
|
Diethyl Phosphate, 98% (Titr.)
| 598-02-7 |
|
2-Amino-4,6-Dihydroxypyrimidine, 98%
| 56-09-7 |
|
N-alpha-FMOC-L-Arginine, 99+%
| 91000-69-0 |
|
Ethyl Disulfide, 99% (GC)
| 110-81-6 |
|
4-Carboxybenzo-18-Crown-6, 99%
| 60835-75-8 |
|
Methyl 2-hydroxy-2-methoxyacetate, 95%
| 19757-87-2 |
|
Tetradecanedinitrile, 95%
| 0-01-1 |
|
Pentafluorobenzenesulfenyl chloride
| |
|
Ammonium Sulfamate, Reagent ACS, 98+% (Titr.)
| 7773-06-0 |
|
2-Bromoindanone tech., 88-92%
| 1775-27-5 |
|
Trans-Stilbene, Scintillation Grade
| 103-30-0 |
|
4-Methylbenzyl Alcohol 98%
| 589-18-4 |
|
2,6-Diaminotoluene, 98%
| 823-40-5 |
|
2,6-Dichloro-4-Methylsulphonyl Phenol, 95+%
| 20951-05-7 |
|
Piperonylamine, 97%
| 2620-50-0 |
|
Undecanophenone, 98%
| 4433-30-1 |
|
2,4-Pyridinedicarboxylic Acid, 99+%
| 499-80-9 |
|
Dimethyl oxalate 99%
| 553-90-2 |
|
2-Amino-5-(4-nitrophenylsulfonyl)- thiazole
| 39565-05-4 |
|
exo-2-Bromonorbornane, 98%
| 2534-77-2 |
|
10,11-Dihydrocarbamazepine, 99%
| 3564-73-6 |
|
3,4-Dibromotoluene, 98+%
| 0-00-1 |
|
Cyclohexylmethanol, 99%
| 100-49-2 |
|
5-Chlorobenzoxazole, 99%
| 17200-29-2 |
|
4-Tert.-Butylcyclohexanecarboxylic Acid 99%, Cis/Trans Mixture
| 5451-55-8 |
|
Lauric acid sodium salt, 99% (titr.)
| 629-25-4 |
|
Bis(triphenyltin) oxide
| 1262-21-1 |
|
|